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ABSTRACT
Introduction Delirium is a dangerous syndrome of acute
brain dysfunction that is common in the emergency
department (ED), especially among the geriatric
population. Most systematic reviews of interventions
for delirium prevention and treatment have focused on
inpatient settings. Best practices of effective delirium care
in ED settings have not been established. The primary
objective of this study is to identify pharmacologic and
non-pharmacologic interventions as applied by physicians,
nursing staff, pharmacists and other ED personnel to
prevent incident delirium and to shorten the severity and
duration of prevalent delirium in a geriatric population
within the ED.
Methods and analysis Searches using subject headings
and keywords will be conducted from database inception
through June 2020 in MEDLINE, EMBASE, Web of Science,
PsychINFO, CINAHL, ProQuest Dissertations and Theses
Global and Cochrane CENTRAL as well as grey literature.
Database searches will not be limited by date or language.
Two reviewers will identify studies describing any
interventions for delirium prevention and/or treatment in
the ED. Disagreements will be settled by a third reviewer.
Pooled data analysis will be performed where possible
using Review Manager. Risk ratios and weighted difference
of means will be used for incidence of delirium and other
binary outcomes related to delirium, delirium severity or
duration of symptoms, along with 95% CIs. Heterogeneity
will be measured by calculating I2, and a forest plot
will be created. If significant heterogeneity is identified,
metaregression is planned using OpenMeta to identify
possible sources of heterogeneity.
Ethics and dissemination This is a systematic review
of previously conducted research; accordingly, it does
not constitute human subjects research needing ethics
review. This review will be prepared as a manuscript and
submitted for publication to a peer-reviewed journal, and
the results will be presented at conferences.
PROSPERO trial registration number CRD42020169654.

INTRODUCTION
Delirium is an acute confusional state characterised by declines in attention, awareness
and cognition. Fluctuations of mental status
over time are characteristic and necessary
for diagnosis.1 2 Delirium is common in the
acute care setting including the emergency

Strengths and limitations of this study
►► This study will utilise three reviewers to analyse ar-

ticles and resolve discrepancies of data collection.
►► Study will be conducted with a well-defined search

strategy including a search of unpublished and grey
literature.
►► Study will search a broad group of databases to
identify studies produced by physicians, nurses,
pharmacists and other researchers.
►► There will be increased heterogeneity due to the
large number of interventions included.
►► Some outcomes, such as delirium duration, may
be assessed differently in each study, limiting the
analysis.

department (ED), and is particularly prevalent among adults older than 65 years.
As many as 7%–17% of older adults who
present to the ED meet diagnostic criteria
for delirium.3–9 ED providers miss delirium
in up to 80% of cases.6 ED delirium is associated with significantly increased in-hospital,
30-day and 6-month mortality, as well as loss
of independence,5 9–11 accelerated cognitive
decline and post-
traumatic stress disorder
which are especially troubling to patients and
their families.11 12 Delirium can be characterised by motor subtypes—namely hypoactive
(92%), hyperactive or mixed delirium (8%).4
Our understanding of delirium prognosis is
evolving through a growing body of literature
exploring associations between classification
of delirium aetiology, motor subtypes and
severities of outcomes.4 13 14
Interventions aimed at reducing the incidence and severity of delirium have been
studied in various settings, but our preliminary searches revealed a paucity of ED
research.15 Multicomponent prevention
programmes in hospitalised patients showed
a reduction in delirium incidence.16 17 Several
Cochrane reviews have been published
since 2012, which reported the utility
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of pharmacological agents,18 19 delirium prevention
programmes in hospital setting16 and long-term care.20
Thus, both pharmacologic and non-
pharmacologic
interventions applied by physicians, nursing staff, pharmacists and other ED personnel could have a role in
reducing the incidence, severity or duration of delirium
in the ED, as reported in the studies from other practice
settings including inpatient medical, surgical and palliative care units and long-term care facilities.16–19 21–24
The ED is a critical setting for delirium screening and
preventative measures, since more than half of geriatric
hospitalisations begin in the ED.25
Clearly identifying, preventing and treating delirium is
critical for improved patient care. Recognising the importance of improved delirium evaluation, management and
prevention, the American College of Emergency Physicians developed an electronic tool, the ADEPT tool, to
help improve care provided of older adults with or at risk
of delirium in the ED.26 ADEPT stands for Assess, Diagnose, Evaluate, Prevent, and Treat, and is used as a checklist to aid in the care of the confused and agitated elderly
patient. The purpose of this study is to better understand which delirium prevention or treatment strategies
provide the most compelling evidence of effectiveness
and feasibility in ED settings.
Objective of systematic review and meta-analysis
This review aims to identify pharmacologic and non-
pharmacologic interventions as applied by physicians,
nursing staff, pharmacists and other ED personnel to
prevent incident delirium and to shorten the severity and
duration of prevalent delirium in a geriatric population
within the ED.

METHODS AND ANALYSIS
Protocol design and registration
The study is a systematic review and meta-
analysis to
summarise randomised controlled trials and quasi-
experimental studies. The study protocol adheres to the
Preferred Reporting Items for Systematic Reviews and
Meta-
analysis Protocols (PRISMA-
P; see online supplemental table 1).27
Study characteristics
This review will consider quasi-
experimental or
randomised controlled trial designs that evaluate the
effectiveness of a prevention or treatment intervention(s)
for all forms of delirium (ie, hypoactive, hyperactive and
mixed subtypes), evaluating incidence and severity of
delirium as primary outcomes. This review will exclude
studies solely focused on delirium tremens or emergence delirium, but will not exclude studies that include
these diagnoses as part of a broader delirium definition.
Published studies, studies that are pending publication,
and unpublished studies will be included to reduce the
bias of selective outcome reporting. Further inclusion
and exclusion criteria are listed in table 1.
Types of participants
This systematic review will include studies where participants are aged 65 or older who present initially to the ED
and are evaluated for delirium. We will include studies
that use subjects under the age of 65 if they also report
data on people over age 65.
Types of interventions
Interventions of interest are those aimed at prevention or
treatment of delirium. Prevention will be defined as any

Table 1 Eligibility criteria
PICOS
strategy

Inclusion criteria

Exclusion criteria

Population
Intervention

Age 65 or older, initial presentation to the ED
Multicomponent interventions, single component non-pharmacologic
interventions performed by physicians, nursing staff and pharmacists,
pharmacologic interventions performed by physicians, nursing staff and
pharmacists

None
None

Comparator

Usual care

None

Outcomes

Primary outcomes:

Absence of the use of
validated delirium assessment
tool for delirium diagnosis or
severity

Incidence of delirium (prevention study)
Severity of delirium (treatment study)
Secondary outcomes (treatment study):

Study design

Delirium duration
In-hospital and long-term mortality, discharge to skilled nursing facility, long-
term quality of life, functional status and long-term cognition
Randomised controlled trials, quasi-experimental studies

None

ADEPT, Assess, Diagnose, Evaluate, Prevent, Treat; DSM, Diagnostic and Statistical Manual of Mental Disorders; GRADE, Grades of
Recommendation Assessment, Development and Evaluation; ICD, International Classification of DIsease; PICOS, Population, Intervention,
Comparison, Output, Study.
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method employed specifically to reduce the incidence
of delirium. Treatment will be defined as any treatments
aiming to reduce the severity or duration of diagnosed
delirium. Both single-component and multicomponent
non-pharmacologic interventions will be considered for
this systematic review. All pharmacologic interventions
such as typical and atypical antipsychotics, benzodiazepines, alpha-2 agonists, sedatives, opioids, cholinesterase
inhibitors, melatonin and melatonin receptor agonists
will be considered for inclusion. Single-component and
multicomponent non-
pharmacologic interventions as
well as pharmacologic interventions will be included if
performed by a physician, nurse, pharmacist or other ED
staff.
Types of outcome measures
For all outcome measures, delirium should be defined
and assessed in triage, ED or inpatient by a validated or
acceptable diagnostic tool for delirium reported in the
peer-reviewed journal, including Single Question to Identify Delirium, Ultrabrief two-item Bedside Test, Delirium
Triage Screen, 4AT, brief Confusion Assessment Method,
applicable diagnostic tools listed on the Delirium Severity
Measures Summary Table developed by the Network for
Investigation of Deliurium: Unifying Scientists (NIDUS),
ICD 10 criteria and DSM IV/V diagnosis.28 29 Delirium
severity will be measured initially in triage or the ED using
any of the existing tools defined in the Delirium Severity
Measures Summary Table developed by NIDUS, or as
defined in the specific study.29 The primary outcomes will
be incidence of delirium for any prevention study and
severity of delirium for any treatment study.
Secondary outcomes for any treatment study will
include delirium duration. Duration will be defined
using each study’s respective definition of duration, and
or measured as first instance of multiple consecutive positive tests until time of first instance of multiple consecutive negative tests for studies that include such data. We
will also include all-cause mortality, in-hospital mortality,
level of care, discharge to skilled care facility, any type of
fall, quality of life and long-term cognitive impairment.
In-hospital mortality will be defined as any death while
in the ED or during the initial admission. Level of care
will be defined categorically as discharge to home, admission to a step-down unit, or admission to an intensive care
unit. Discharge to a skilled care facility will be assessed
as new placement in a skilled nursing home immediately
following the initial ED visit and primary hospital admission, but not including home health nursing. Long-term
quality of life, functional status, and long-term cognition
will be included as a secondary outcome if assessed using
a validated, non-disease specific tool (such as the Activities of Daily Living Questionnaire).
Types of studies
Both randomised controlled trials and quasi-experimental
studies will be included.
Dahlstrom EB, et al. BMJ Open 2020;10:e037915. doi:10.1136/bmjopen-2020-037915

Timing
We will use timing parameters that extend throughout
the hospital stay and up to a 180-day follow-up.
Setting
This review will be restricted to studies where initial
delirium assessment starts in the ED or in triage and
subsequent intervention(s) starts in triage, the ED or
inpatient wards. This is because more than 50% of older
adults who required hospitalisation are admitted through
the ED, and effective screening, treatment and delirium
prevention programme can have a significant impact on
the remainder of their hospital stay.25
Information sources
Strategies for searching the literature will be developed
to locate studies relating to the concepts; delirium, ED,
interventions and the geriatric population. The strategies
will use subject headings and keywords. A librarian (HH)
will conduct searches in MEDLINE (Ovid), EMBASE
(Elsevier), Web of Science, PsycINFO (EBSCOhost),
CINAHL, ProQuest Dissertations and Theses Global and
Cochrane CENTRAL (Wiley). The search strategies will
not be limited by language. Each database will be searched
from database inception through June 2020. The team
will supplement the electronic database searches by
looking for trial protocols and ongoing studies through
ClinicalTrials.
gov and PROSPERO. Additional unpublished sources and conference abstracts will be sought
out directly from conference proceedings and primary
authors. For each included article, the reference list will
be searched for additional relevant studies.
Search strategy
The specific search strategies for each database will be
developed by a health sciences librarian (HH) trained
in systematic review searching. The team will provide
input on the terminology for the strategies, and the strategies will be peer reviewed, using the PRESS guideline,
by another health sciences librarian.30 A draft PubMed
search strategy follows in online supplemental file.
Clinicaltrials.gov and PROSPERO will be searched for
incomplete or recently completed studies. As the paucity
of literature exists in the prevention and intervention of
delirium in the ED, we will identify any preliminary or
unpublished study through the content experts (JHH,
MK, GA and JL).
Data management
Database search results will be transferred to EndNote
and deduplicated using the published methodology
for deduplication as laid out by Bramer, Giustini and
de Jonge.31 Citations will be stored and sorted using
Endnote. Data will be compiled and meta-analysed using
Review Manager (RevMan, V.5.3; The Nordic Cochrane
Centre, The Cochrane Collaboration). OpenMeta
(Analyst) (Center for Evidence-Based Medicine, Brown
School of Public Health) will be used for regression with
continuous covariates.
3

BMJ Open: first published as 10.1136/bmjopen-2020-037915 on 6 October 2020. Downloaded from http://bmjopen.bmj.com/ on November 16, 2020 at Washington University School of
Medicine Library &. Protected by copyright.

Open access

Selection process
This review will follow the PRISMA standards for reporting
a systematic review and meta-analysis.27 Studies identified
via the search strategy and other methods will undergo
an initial review by two independent reviewers who will
review the title and abstract to determine whether the
study meets the defined inclusion criteria. Studies where
there is disagreement between the reviewers will be
included in the secondary review.
Selected studies will subsequently be subjected to full-
text review, again with two independent reviewers utilising inclusion and exclusion criteria. A third reviewer will
settle disagreements. We will report the kappa to measure
inter-rater reliability. This analysis will be documented in
a PRISMA flow diagram, and the process will result in a
final list of included articles.

with no selection biases. We will assess publication bias
using funnel plots.

Data collection
Reviewers will use a standardised data collection form
to gather desired information (see online supplemental
table 2). The form will be developed following the
style outlined by ‘Data collection form for intervention
review—RCTs and non-RCTs’ from the Cochrane Collaboration.32 Data collection will be done independently.
Calibration exercises will be used prior to conducting the
review to ensure that each reviewer is consistent with their
data collection. A third reviewer will check for discrepancies between data sheets for each given article and settle
any disagreements. We will reach out to original study
authors for details or data if any uncertainties arise.

Subgroup analysis
Subgroup analysis will be conducted based on type of
intervention (pharmacologic and non-
pharmacologic),
delirium motor subtype (hyperactive, hypoactive, mixed),
delirium severity, presumed delirium aetiology (phenotype)
and whether incident or prevalent delirium was studied.
Possible sources of heterogeneity tested includes age, antipsychotics, delirium subtype and study year. A linear meta-
regression model weighted to reflect the variance of the
individual studies will be used to model the data.

Data items
We will collect data on the year of publication, study
design, method of evaluating for delirium or delirium
severity, and interventions for delirium prevention and/
or treatment. We will extract data on outcomes, including
incidence of delirium, duration of delirium, delirium
severity, mortality (30-day and in-hospital), new admission
to a skilled nursing facility after ED visit, admission to an
intensive care unit, quality of life and persistent cognitive
deficits for intervention and control groups.
Risk of bias assessment
The study will use the Cochrane risk of bias assessment
tool for randomised clinical trials and New-Castle-Ottawa
scale for quasi-
experimental studies for quality assessments.33–35 Direct quotes from each study will be used for
all subsections of the tool in order to assess the risk of bias.
Two independent reviewers will assess risk of bias, and the
third reviewer will settle any discrepancy. We will report
kappa to report the inter-rater agreement. The quality of
evidence for an association between treatment, prevention and delirium-related outcomes will be evaluated in
accordance with the GRADE system.36 This system grades
quality of evidence at four levels: high (4), moderate (3),
low (2) and very low (1). For high evidence, the requirements are a randomised, double-
blinded study design
4

Data synthesis
If the studies, or an adequate subset of the studies in the
review have sufficiently homogeneous outcomes data,
analysis will be conducted. Data associated with
meta-
primary and secondary outcomes will be analysed in
aggregate. For dichotomous data, risk ratios will be calculated with 95% CIs. A weighted difference of means will
be used for continuous data with 95% CIs. Heterogeneity
will be assessed using demographic features (age, sex) as
well as study design factors (such as treatment type), and
an I2 value will be calculated. A value of less than 50% will
be considered sufficiently homogeneous.37 Forest plots
will be created using this data. Individual outcomes will
be combined and calculated using RevMan V.5.3.38

Patient and public involvement
Patients and the public were not directly involved in the
development of the research question or the design of the
study, however many of the outcome measures (including
quality of life, level of care and functional status) were
chosen specifically to study the impact of delirium prevention and treatment measures on the patient experience.
This study was conducted without direct patient involvement and patients were not involved in patient recruitment or conduction of the study.
Amendments
Amendments to this protocol, particularly database
searches, will be documented in PROSPERO.
ETHICS AND DISSEMINATION
There will be no human subject participants involved in
this review. The results of this review will be submitted
for publication to a peer-reviewed journal. Other dissemination may include presentations at conferences and
seminars.
DISCUSSION
Delirium is common and serious geriatric syndrome for
which prevention and treatment best practices have not
been established in the ED setting.39 One of the strengths
of this study is that it will compile the relevant evidence
for delirium prevention and intervention within the ED
setting to identify any effective strategy. Another strength
Dahlstrom EB, et al. BMJ Open 2020;10:e037915. doi:10.1136/bmjopen-2020-037915
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Table 2 A list of Cochrane reviews examining delirium
intervention since 2012
Study author/year Main intervention

Setting*

Woodhouse et al
(2019)20

Software-based
identification of high-risk
medication

Long-term care

Burry et al (2018)40

Antipsychotic agent

Non-ICU inpatient
ward

Herling et al
(2018)41

Delirium prevention study
(pharmacological)

ICU

Yu et al (2018)19

Cholinesterase inhibitor

Non-ICU inpatient
ward

Punjasawadwong
et al (2018)42

Electroencephalogram

Perioperative

Siddiqi et al (2016)16 Delirium prevention study Mixed setting
(pharmacological and non- (none ED)
pharmacological treatment)
Candy et al (2012)18 Pharmacological therapy

Delirium with
AIDS in the
palliative care

*We were unable to identify any review in the ED.
ED, emergency department; ICU, intensive care unit.

of this study is that it will be conducted using a well-
defined search strategy. We will consult transdisciplinary
delirium for grey literature, unpublished works and
ongoing studies to minimise the risk of bias of selective
outcome reporting.
The review will explore a new insight to prevention
and treatment options to employ in the ED, which have
become the main entrance for the majority of older
adults to the hospital. The clinical care delivered in
the ED influences downstream clinical care and therefore, may have a significant impact on outcomes. We
are aware of a total of seven Cochrane reviews published
since 2012 that examine the various delirium prevention
and treatment interventions in varied clinical settings
(table 2).16 18–20 40–42
One Cochrane review examined the effect of antipsychotic agents for delirium treatment in non-ICU hospitalised patients and found no impact on delirium severity
or duration.40 Due to limited research in the palliative
care setting, evidence was deemed insufficient to assess
the impact of pharmacologic therapies for the treatment
of delirium in terminally ill patients.18 Similarly, the
data were deemed insufficient to evaluate the effect of
cholinesterase inhibitors in the treatment of delirium in
the non-ICU hospital setting. A review evaluating prevention strategies in long-term care settings found limited
evidence on interventions for preventing delirium, but
a software-based intervention to identify high-risk medications and a pharmacist-led medication review reduced
the incidence of delirium.20 There is strong evidence
that a multicomponent delirium prevention programme
reduces the incidence of delirium in the non-
ICU
hospital setting. Despite the ample number of systematic
Dahlstrom EB, et al. BMJ Open 2020;10:e037915. doi:10.1136/bmjopen-2020-037915

reviews, it is important to note that none of these focused
on delirium interventions in the ED (table 2).
Our study protocol may have limitations, including
increased heterogeneity due to the large number of
different interventions being included. There may also
be limitations to the statistical power of our findings
depending on the quantity of literature in this setting.
Although we set a comprehensive list of outcomes, it
may not be possible to find any studies that list them, for
example, quality of life.
The importance of delirium prevention and management in the ED setting is underscored by the inclusion of
delirium recognition and management as a best practice
in the Geriatric ED Guidelines,43 a quality indicator for
geriatric emergency care,44 a core competency for emergency medicine residents45 as well as by the recent dissemination of the ADEPT tool.26 Although guidelines and
core competencies reflect the expert consensus-
based
best practices in EM, high-
quality research evidence
to support ED delirium prevention and intervention
approaches have been lacking. This review will address
a critical need to synthesise research into delirium
prevention and management in the ED setting to further
improve the care of older ED patients with or at risk for
delirium and create a roadmap for future researchers.46 47
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